135 related articles for article (PubMed ID: 4628156)
1. The development of plasma derivatives in Australia.
Schiff P
Vox Sang; 1972; 23(1):38-43. PubMed ID: 4628156
[No Abstract] [Full Text] [Related]
2. Notes on plasma derivative production in the Federal Republic of Germany.
Schwick HG
Vox Sang; 1972; 23(1):44. PubMed ID: 5081013
[No Abstract] [Full Text] [Related]
3. Plasma fractionation in England and Wales.
Vallet L
Vox Sang; 1972; 23(1):58-60. PubMed ID: 4628157
[No Abstract] [Full Text] [Related]
4. A survey of the production of plasma derivatives for clinical use.
Schwick HG
Vox Sang; 1972; 23(1):82-91. PubMed ID: 4628158
[No Abstract] [Full Text] [Related]
5. Notes on the production of plasma derivatives in France.
Steinbuch M
Vox Sang; 1972; 23(1):56-7. PubMed ID: 4117049
[No Abstract] [Full Text] [Related]
6. The current status of blood fractionation in the United States.
Sgouris JT
Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014
[No Abstract] [Full Text] [Related]
7. New trends in plasma fractionation.
Steinbuch M
Haematologia (Budap); 1983; 16(1-4):39-51. PubMed ID: 6207083
[No Abstract] [Full Text] [Related]
8. Development of plasma derivatives for clinical use.
Tullis JL
Vox Sang; 1972; 23(1):3-9. PubMed ID: 4117048
[No Abstract] [Full Text] [Related]
9. Factors determining quality of plasma.
Myllylä G
Vox Sang; 1998; 74 Suppl 2():507-11. PubMed ID: 9704491
[No Abstract] [Full Text] [Related]
10. The development of plasma derivatives in Switzerland.
Kistler P
Vox Sang; 1972; 23(1):26-31. PubMed ID: 5081011
[No Abstract] [Full Text] [Related]
11. Current approaches to the preparation of plasma fractions.
Vandersande J
Biotechnology; 1991; 19():165-76. PubMed ID: 1786470
[No Abstract] [Full Text] [Related]
12. Notes on the development of plasma derivatives in the Netherlands.
Krijnen HW
Vox Sang; 1972; 23(1):32. PubMed ID: 5081012
[No Abstract] [Full Text] [Related]
13. [Current problems of blood preparations].
From AA
Probl Gematol Pereliv Krovi; 1974 Apr; 19(4):3-7. PubMed ID: 4134108
[No Abstract] [Full Text] [Related]
14. Present state and perspectives of the farctionation of human plasma, serum and placenta.
Richter P
Ann Immunol Hung; 1973; 17():85-92. PubMed ID: 4142679
[No Abstract] [Full Text] [Related]
15. The development of plasma derivatives in Canada.
McVicar GA
Vox Sang; 1972; 23(1):33-4. PubMed ID: 4117046
[No Abstract] [Full Text] [Related]
16. Research and development commitments in an integrated plasma collection and plasma fractionation environment.
Radosevich M
Semin Thromb Hemost; 1998; 24(2):157-61. PubMed ID: 9579637
[TBL] [Abstract][Full Text] [Related]
17. [Extraction of test sera and therapeutic immunoglobulins].
Matthes M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(1):81-94. PubMed ID: 4118784
[No Abstract] [Full Text] [Related]
18. [Plasmapheresis as a method of production of blood fractions].
Lautner A
Bibl Haematol; 1969; 32():212-6. PubMed ID: 5822799
[No Abstract] [Full Text] [Related]
19. Scientific advances in transfusion.
O'Riordan JP
J Ir Med Assoc; 1973 Jan; 66(2):27-36. PubMed ID: 4569809
[No Abstract] [Full Text] [Related]
20. Chromatographic methods of fractionation.
Friesen AD
Dev Biol Stand; 1987; 67():3-13. PubMed ID: 3609484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
